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Abstract
Some polyunsaturated fatty acids (PUFAs), if not all, have been shown to have tumoricidal action, but their exact
mechanism(s) of action is not clear. In the present study, we observed that n-6 PUFA linoleic acid (LA) inhibited
tumor cell growth at high concentrations (above 300 μM); while low concentrations (100-200 μM) promoted prolif-
eration. Analysis of cell mitochondrial membrane potential, reactive oxygen species (ROS) formation, malondialde-
hyde (MDA) accumulation and superoxide dismutase (SOD) activity suggested that anti-cancer action of LA is due
to enhanced ROS generation and decreased cell anti-oxidant capacity that resulted in mitochondrial damage. Of
the three cell lines tested, semi-differentiated colorectal cancer cells RKO were most sensitive to the cytotoxic
action of LA, followed by undifferentiated colorectal cancer cell line (LOVO) while the normal human umbilical vein
endothelial cells (HUVEC) were the most resistant (the degree of sensitivity to LA is as follows: RKO > LOVO >
HUVEC). LA induced cell death was primed by mitochondrial apoptotic pathway. Pre-incubation of cancer cells
with 100 μM LA for 24 hr enhanced sensitivity of differentiated and semi-differentiated cells to the subsequent
exposure to LA. The relative resistance of LOVO cells to the cytotoxic action of LA is due to a reduction in the
activation of caspase-3. Thus, LA induced cancer cell apoptosis by enhancing cellular oxidant status and inducing
mitochondrial dysfunction.
Introduction
Essential fatty acids (EFAs): linoleic acid (LA, n-6, 18:2)
and a-linolenic acid (ALA, n-3, 18:3) form precursors to
their long chain metabolites g-linolenic acid (GLA, n-6,
18:3), dihomo-GLA (DGLA, n-6, 20:3) and arachidonic
acid (AA, n-6, 20:4); and eicosapentaenoic acid (EPA,
n-3, 20:5) and docosahexaenoic acid (DHA, n-3, 22:6)
respectively [1-3]. Our previous studies showed that
polyunsaturated fatty acids (PUFAs) selectively induced
tumor cells apoptosis though the sensitivity of various
cancer cells to different fatty acids were found to be
variable depending on the type of cancer cell being
tested and the type and concentration of the fatty acid
used [3-7].
Previously, it was reported that essential fatty acids
and their metabolites suppress tumor cells growth both
in vitro and in vivo. This tumoricidal action of fatty
acids could be correlated to an increase in generation of
free radicals in the tumor cells [8]. Subsequent studies
showed that most polyunsaturated fatty acids were
functional, and the inhibitory action of different types of
n-3, n-6 and n-9 fatty acids does not depend on their
unsaturation [9]. Among all the fatty acids tested, GLA,
AA, EPA and DHA were found to be the most effective
in inhibiting tumor cells growth, while LA and ALA
were also effective but at much higher concentrations
[3-5]. It was opined that n-6 fatty acids enhance tumor
cell growth whereas n-3 fatty acids are beneficial since
they arrest cancer growth. This differential action of n-3
and n-6 PUFAs in cancer has been attributed to the for-
mation of pro-inflammatory eicosanoids from n-6
PUFAs whereas products formed from n-3 PUFAs are
much less pro-inflammatory in nature [1-7,10-13],
though Trombetta A, etc.r e p o r t e dt h a tA A ,a nn - 6
PUFA, decreased human lung-tumor cell growth in a
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death mainly evident at 100 mM concentration [14].
In the majority of previous investigations, n-3 and n-6
PUFAs were added to the tumor cell medium in vitro
without a simultaneous study of these fatty acids on
normal cells. Hence, it is not clear whether the concen-
trations of fatty acids used in these studies are non-toxic
to normal cells at which they were found to be cytotoxic
to tumor cells. In addition, little attention was paid to
the ratio between n-6 and n-3 fatty acids as they exist in
the body while performing these studies. It is important
to note that in the plasma, n-6 PUFAs are present in
large amounts compared to n-3 fatty acids (the ratio
between n-6 PUFAs compared to n-3 PUFAs is ~7:1 in
the serum) [15]. Furthermore, PUFAs are widely distrib-
uted in our food and hence, there could be a wide varia-
tion in the daily intake of these fatty acids among
different populations and individuals depending on the
type of diet and the quality of the food ingested. In gen-
eral, the level of total fatty acids in the plasma/serum is
~200 mg/dl, and of which the percentage of LA is ~20%
regardless of the differences in dietary pattern [15].
Previously, we observed that the action of LA on can-
cer cell growth depended on the type of cancer cells
being tested and the concentration of fatty acids supple-
mented [3-7]. LA ~40 μg/ml/1 × 10
4 cells inhibited the
growth of cancer cells whereas lower concentrations ~5-
10 μg/ml/1 × 10
4 cells enhanced growth of some, if not
all, types of cancer cells that were being tested [11]. In
the present study, we evaluated the effect of the fatty
acid on three cell lines, two of which were colorectal
cancer cell lines, LOVO (undifferentiated) and RKO
(semi-differentiated), and the human umbilical vein
endothelial cells (HUVEC) taken as normal cell control
in order to clarify the role of LA in the promotion and
inhibition of the growth of cancer cells in vitro. In order
to know the sensitivity of tumor cells to LA, in one set
of studies we pre-incubated the cells for 24 hours with
100 μM of LA and then were subsequently exposed to
various doses of LA to know whether the initial expo-
sure to LA affects the survival of tumor cells.
Materials and methods
Materials
Linoleic acid (LA, 18:2 n-6) was obtained from Sigma
(St. Louis, MO, USA). The colorectal cancer cell lines,
LOVO (undifferentiated) and RKO (semi-differentiated),
and normal cell line HUVEC (human umbilical vein
endothelial cells) were obtained from Shanghai Institute
of Cell Biology, Chinese Academy of Sciences. PRMI
medium 1640 and high-glucose DMEM Nutrient Mix-
ture medium were purchased from GIBCO (Grand
I s l a n d ,N Y ,U S A ) .M T T( 3 - ( 4 ,5 - dimethylthiazolyl-2)-2,
5-diphenyltetrazolium bromide) was provided by
Shanghai Sangon Biological Engineering Technology &
Services Co., Ltd. All other chemicals were of extra-pure
grade or analytical grade.
Cell culture and treatment
Colorectal cancer cells (LOVO and RKO) and human
normal cells (HUVEC) were cultured in PRMI Medium
1640 and high-glucose DMEM Nutrient Mixture med-
ium separately, supplemented with 10% fetal bovine
serum and 100 U/ml penicillin-streptomycin in a humi-
dified 37°C, 5% CO2 incubator (Shellab, USA).
LA was dissolved in 0.1 N NaOH and diluted to give a
final concentration of 20 mM with the final concentra-
tion of NaOH was no more than 0.005 N, a concentra-
tion of NaOH at which it had little affect on the cells.
Stock solutions were filter-sterilized and diluted with
cell culture media for use in the study [16].
Both the colon cancer cells (LOVO and RKO) and
normal cell (HUVEC) were treated with LA in two dif-
ferent ways: in the first group, the cells were cultured in
the cell culture medium alone for 24 h prior to treat-
ment with different doses of LA; whereas in the second
group, cells were pre-incubated with 100 μML Af o r2 4
hr followed by treatment with different doses of LA as
was done in the first group.
Cell growth and viability assay
Cell proliferation was assessed using MTT assay (Roche,
Mannheim, Germany). At different time intervals after
incubation with LA, the number of viable cells grown in
a 96-well plate was estimated by adding 20 μlo fM T T
solution (5 mg/ml in PBS). After 4 hr of incubation at
37°C, the stain was diluted with 150 μlo fD M S O .T h e
absorbance in each well was then measured with a
microplate reader (Thermal Lab system, Finland) at
492 nm, and viability of cells was presented as percen-
tage of the control [16]. Each treatment was replicated
at least five times.
Mitochondrial membrane potential detection
Cells (1 × 10
6 c e l l s )o b t a i n e df r o mc o n t r o la n dv a r i o u s
LA treatments were washed thrice with PBS, and resus-
pended at a final protein concentration of 0.75 mg/ml
in PBS, 100 μl was taken for the following detection.
100 ng Rh123 (Rhodamine 123) were added to each
s a m p l e .U p o ni n c u b a t i o ni nt h ed a r k( 1 5m i n ,a tr o o m
temperature or 30 min at 4°C), the samples were washed
with 300 μl PBS twice. The cells were resuspended in
200 μl PBS for analysis. Fluorescence intensity was car-
ried out on a multifunctional micro-plate reader (Spec-
traMax M5, Molecular Devices) with a 96-well plate
(side-opaque, clear bottom). The excitation and emis-
sion wavelengths for Rh123 were selected with mono-
chromators set to 488 nm (5 nm slit width) and 530 nm
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cated thrice, and the final data was calculated as follows:
corresponding fluorescence intensity (%) = Fsample/FCK
Where: Fsample and FCK are the intensities measured
with microplate reader. [17]
ROS generation studies
Cells were incubated with the cell permeant dye
H2DCF-DA, which intracellularly de-esterifies to
dichlorodihydrofluorescein (H2DCF). ROS oxidize
H2DCF to the brightly fluorescent compound 2-, 7-
dichlorofluorescein (DCF), which was monitored by flow
cytometry following a previously described method [18]
with modifications. Briefly, cells treated with LA or vehi-
cle were incubated with 5 μMH 2DCF-DA for 15 min at
37°C, detached from the plate with trypsin/EDTA,
washed with PBS, resuspended in ice-cold PBS, and
tested immediately. Triplicate samples were run in each
experiment, and at least 5000 cells per sample were ana-
lyzed (excitation at 488 nm, emission at 500-530 nm) by
SpectraMax M5, Molecular Devices. Mean fluorescence
was calculated by using the program SoftMax Pro Soft-
ware Version 5 for Mac® and Windows®.T h ef i n a ld a t e
was calculated as given below:
Corresponding fluorescence intensity (%) = Fsample/
FCK
Where: Fsample and FCK are the intensities measured
with microplate reader.
Estimation of cell MDA content and SOD activity
The levels of MDA and the activity of SOD, the biomar-
kers of oxidative stress, were measured as described pre-
viously with commercial reagent kits purchased from
Nanjing Kaiji Bioengineering Institute (Nanjing, China)
[19]. The cell MDA content and SOD activity were also
represented as corresponding value:
Corresponding MDA (or SOD) concentration (%) =
Csample/CCK
Where: Csample and CCK are the concentration of
MDA (or SOD) measured with regent kits.
Isolation and purification of mitochondria
The cells were harvested by centrifuging at 1,500 rpm
for 5 min at 4°C, and washed twice with cold PBS and
finally re-suspended in PBS. Cells were lysed by Ultraso-
nic Cell Disruption System (JY92-II, Chongqing, China)
and centrifuged at 3,000 rpm for 10 min at 4°C. The
supernatant thus obtained was centrifuged at 9,000 rpm
for 10 min to obtain mitochondrial pellets that
were washed twice with cold PBS. The final mitochon-
drial pellets were suspended in test medium (220 mmol/
L Mannitol, 70 mmol/L Sucrose, 5 mmol/L HEPES, pH
7.2) for the following studies. The final protein con-
centrations of the mitochondrial suspension were all
adjusted to 0.3 mg/mL (detected and corrected
with Bradford protein analysis kit, Sangon, Shanghai,
China) [20].
Measurement of cytochrome C content
Isolated mitochondrial content of cytochrome C was
measured at 520 nm in UV-vis spectroscopy (HP 8453,
Hewlett-Packard, USA) by suspending them in a reac-
tion medium containing 10 mg sodium dithionite and
0 . 5m Lo f0 . 3m g / m Lm i t o c h o n d r i a lp r o t e i n .S a m p l e
concentrations were determined based on a standard
curve. Each of the experiments was replicated three
times [20].
Measurement of the activities of caspases 9 and 3
The activities of caspases 9 and 3 were assayed using
caspase-9 and caspase-3 activity assay kits separately,
according to the manufacture’si n s t r u c t i o n s( K e y g e n ,
Nanjing, China). After different treatments, 5 × 10
6 cells
were harvested by centrifuging at 1,500 rpm for 5 min
at 4°C, and washing twice with cold PBS, then resus-
pended in a cell lysis buffer. After incubation on ice for
60 min, the lysates were centrifuged for 20 min at
12,000 rpm, the supernatants were collected and protein
concentrations were determined. Cell lysates (100 μg)
were mixed with reaction buffer and incubated for 4 h
at 37°C. The absorbance of the reaction mixture was
measured in the wells at 405 nm using an ELISA reader
(Thermal Labsystem, Helsinki, Finland) [20].
Statistical analysis
All results are expressed as means ± SD and significance
of differences between various results was determined by
Origin 7.0. Each treatment was carried out at least
triple, and statistic analysis was shown as: *meaning
p < 0.05, and for ** meaning p < 0.01.
Results
Cell growth and viability
All the three cell lines studied showed increased cell
proliferation at lower concentrations of LA (100-200
μM), while higher concentrations of LA (above 300 μM)
suppressed the growth of the cells as determined by
MTT assay (Fig. 1).
It is interesting to note that different cell lines showed
different sensitivity to LA depending on the type of cell
line being tested and the dose of LA supplemented (Fig.
1). Of three types of cells tested, HUVEC were the most
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two cancer cell lines used in the present study. The col-
orectal cancer cell lines showed increased or no change
in proliferation when exposed to 100 μML Aw h e r e a s
HUVEC cells remained non-responsive even when
supplemented with 400 μM LA. LA suppressed the pro-
liferation of LOVO and RKO cells to a significant degree
when supplemented with 300 μM of LA, whereas
HUVEC cells showed decreased proliferation only when
incubated with 600 μM of LA. Based on these results,
Figure 1 MTT assay results. The three figures are the results of the cell proliferation assay of HUVEC, LOVO, and RKO cell lines separately. In
each figure, “12 h, 24 h, 36 h” means cells were cultured with gradient LA treatment after 12 hour, 24 hour, 36 hour with no linoleic acid
medium and incubated for 24 h; “12 h p, 24 h p, 36 h p” means cells were cultured with 100 μM LA for 24 hr before gradient LA treatment.
Each treatment was carried out at least five times.
Lu et al. Lipids in Health and Disease 2010, 9:106
http://www.lipidworld.com/content/9/1/106
Page 4 of 11we chose 200 μM and 400 μM for treatment of HUVEC,
while 100 μMa n d3 0 0μM LA was used to study the
effects of LA on colorectal cancer cells for subsequent
studies.
On the other hand, when we studied the effect of pre-
incubation of cells with 100 μM of LA for 24 hours fol-
lowed by further exposure to various doses of LA, it was
noted that the sensitivity of HUVEC to the growth sup-
pressive action of LA was enhanced. For instance, it was
noted that almost 50% of HUVEC were still surviving
even when treated with 400 μM LA after pre-treatment.
Of the two cancer cell lines studied, LOVO cells were
found to be resistant to the growth suppressive actions
of LA even when exposed to 300 μM LA after pre-treat-
ment, while, RKO cells showed increased sensitivity to
the growth suppressive action of the fatty acid. Hence,
we performed all subsequent mechanistic studies with
HUVEC, LOVO and RKO cells by pre-incubating them
with 100 μM for 24 hours followed by subsequent sup-
plementation with LA as described.
Cell mitochondrial membrane potential detection
Cell mitochondrial membrane potential was evaluated as
a measure of the degree of injury to the mitochondrial
membrane which is reflected in the amount of perme-
ability exhibited to Rh123 (Fig. 2): the higher the perme-
ability the higher fluorescence of Rh123 could pass-
through mitochondrial membrane indicating statically
significant damage to the membrane.
HUVEC did not show any significant change in the
cell mitochondrial membrane potential following the
addition of LA, while the two cancer cell lines LOVO
and RKO showed significant yet similar changes in the
mitochondrial membrane potential in response to incu-
bation with various treatments with LA. Higher concen-
tration of LA (300 μM) with and without pre-treatment
enhanced mitochondrial uptake of Rh123 by LOVO and
RKO cells compared with their respective controls,
while the low concentration treatments (100 μMo fL A )
did not show any significant change in mitochondrial
membrane fluorescence permeability of Rh123 (Fig. 2).
It is noteworthy that both LOVO and RKO cells showed
similar increase in the mitochondrial membrane fluores-
cence permeability of Rh123 in response to incubation
with 300 μM of LA with or without pre-incubation (Fig.
2).
Pre-incubation with LA increased fluorescence inten-
sity of LOVO and RKO cells, but not of HUVEC, sug-
gesting that HUVEC are able to maintain their
mitochondrial function while the colon cancer cells
could not. In addition, pre-incubation of RKO cells with
LA (100 μM) and subsequent exposure to 300 μMo f
LA led to a much higher fluorescence intensity of
Rh123 in comparison to LOVO cells. The higher fluor-
escence intensity of Rh123 by RKO cells, the semi-dif-
ferentiated cells, in comparison to the fluorescence
intensity by LOVO cells, the undifferentiated cells, in
response to the same dose of LA could be related to the
cell differentiation state. The higher fluorescence inten-
sity of Rh123 by LA-treated RKO cells in comparison to
fluorescence intensity shown by LOVO cells indicates
that LA is able to induce much higher damage to the
Figure 2 Cell mitochondrial membrane potential detection. CK means case-control with medium. As LA was dissolved in 0.1 N NaOH, NaOH
group means case-control with reagent. A, B, C, and D were four different treatments of each cell line. For HUVEC: A = 200 μM without LA pre-
treatment, B = 400 μM without LA pre-treatment, C = 200 μM with 100 μM LA pre-treatment, D = 400 μM with 100 μM LA pre-incubation, For
LOVO and RKO cells: A = 100 μM without LA pre-treatment, B = 300 μM without LA pre-treatment, C = 100 μM with 100 μM LA pre-
treatment, D = 300 μM with 100 μM LA pre-incubation. Each treatment was carried out in triplicate and repeated at least twice. *p < 0.05, and
**p < 0.01.
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LOVO cells. These results indicate that RKO cells are
much more sensitive to the toxic actions of LA com-
pared to LOVO cells.
Cell oxidative stress analysis
In order to know the degree of oxidative stress that
occurred as a result of incubation with LA, we studied
generation of ROS, MDA accumulation, and SOD activ-
ity in the cells.
The amount of ROS generated by HUVEC when incu-
bated with 200 μM LA with and without pre-incubation
was at least 2 to 2.5 times higher compared to the
untreated control while exposure to 400 μM of LA pro-
duced much less (only about 50% rise) increase (Fig. 3).
In contrast, both the colorectal cancer cell lines RKO
and LOVO studied showed much less significant change
in the generation of ROS in response at both doses of
LA (100 and 300 μM) added. There was no significant
difference in the amount of ROS generated with or
without pre-incubation with 100 μM of LA in colorectal
cancer cell lines.
In contrast to the results obtained with regard to ROS
generation, the accumulation of MDA in the cells
showed distinctly different results. There were no signif-
icant changes in the levels of MDA accumulation in
HUVEC following incubation with different doses of LA
(Fig. 4), while colorectal cancer cells LOVO and RKO
showed about 2 ~2.5 times increase compared to
respective controls. Pre-incubation with LA (100 μM)
significantly enhanced MDA accumulation in LOVO,
while RKO cells showed enhancement in the MDA
levels upon treatment with LA with and without pre-
incubation with 100 μM of LA compared to the respec-
tive controls (Fig. 4).
LA treatment raised SOD activity in RKO cells to a
significant degree in a time and dose dependent fashion
(Fig. 5), while the there were no significant changes in
SOD activity in HUVEC and LOVO cells.
Cell mitochondrial apoptosis pathway analysis
Cytochrome C release induces mitochondrial dependent
apoptosis. An enhanced release of cytochrome C was
noted in HUVEC treated with LA with and without pre-
incubation with LA (100 μM) (Fig. 6). An increased
release of cytochrome C was noted in both LOVO and
RKO cells treated with LA with or without pre-treat-
ment. It is noteworthy that the release of cytochrome C
was much higher in cells that were treated with higher
dose of LA (300 μM) with or without pre-incubation
with LA (Fig. 6).
Enhanced release of cytochrome C activates caspase
family that induces cell apoptosis. As expected, the
changes in the activation of caspases 9 and 3 paralleled
the changes seen with cytochrome C release in HUVEC,
LOVO and RKO cells (Fig. 7 and 8). RKO cells showed
much higher increases in the activation of caspase 3
compared to caspase 9, while LOVO cells showed much
less activation of caspase 3 compared to caspase 9.
Discussion
N-6 PUFAs are known for their critical role in many
physiological functions but their role in cancer is still
under debate. Both tumor promoting and inhibiting
Figure 3 Cell ROS (reactive oxygen species) level. CK means case-control with medium. As LA was dissolved in 0.1 N NaOH, NaOH group
means case-control with reagent. A, B, C, and D were four different treatments of the three cell lines. For HUVEC: A = 200 μM without LA pre-
treatment, B = 400 μM without LA pre-treatment, C = 200 μM with 100 μM LA pre-treatment, D = 400 μM with 100 μM LA pre-incubation. For
LOVO and RKO cells: A = 100 μM without LA pre-treatment, B = 300 μM without LA pre-treatment, C = 100 μM with 100 μM LA pre-
treatment, D = 300 μM with 100 μM LA pre-incubation. Each treatment was carried out in triplicate. *p < 0.05, and **p < 0.01.
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been shown that n-6 fatty acids decrease human lung-
tumor cell growth in a concentration-dependent manner
[21,14]. Our results suggested that low concentrations
(≤ 200 μM) of LA promote colorectal cancer cell
growth, while high levels (≥ 200 μM) induce apoptosis
of the colorectal cancer cells in vitro. On the other
hand, low concentrations of LA (≤ 200 μM) did not
promote normal (HUVEC) cell proliferation while high
concentrations (≥ 200 μM), which were cytotoxic to
tumor cells, induced only 10~20% decrease in the num-
ber of HUVEC. These results suggest that LA is toxic to
tumor cells with little or no cytotoxic action on normal
cells.
Mitochondria are the main organelles where fatty
acids and other energy donors are metabolized/
Figure 4 Cell MDA content. CK means case-control with medium. As LA was dissolved in 0.1 N NaOH, NaOH group means case-control with
reagent. A, B, C, and D were four different treatments of the three cell lines. For HUVEC: A = 200 μM without LA pre-treatment, B = 400 μM
without LA pre-treatment, C = 200 μM with 100 μM LA pre-treatment, D = 400 μM with 100 μM LA pre-incubation, For LOVO and RKO cells:
A = 100 μM without LA pre-treatment, B = 300 μM without LA pre-treatment, C = 100 μM with 100 μM LA pre-treatment, D = 300 μM with 100
μM LA pre-incubation. Each treatment was carried out in triplicate and repeated at least twice. *p < 0.05, and **p < 0.01.
Figure 5 Cell SOD activity. CK means case-control with medium. As LA was dissolved in 0.1 N NaOH, NaOH group means case-control with
reagent. A, B, C, and D were four different treatments of the three cell lines. For HUVEC: A = 200 μM without LA pre-treatment, B = 400 μM
without LA pre-treatment, C = 200 μM with 100 μM LA pre-treatment, D = 400 μM with 100 μM LA pre-incubation, For LOVO and RKO cells:
A = 100 μM without LA pre-treatment, B = 300 μM without LA pre-treatment, C = 100 μM with 100 μM LA pre-treatment, D = 300 μM with 100
μM LA pre-incubation. Each treatment was carried out in triplicate and repeated at least twice. *p < 0.05, and **p < 0.01.
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it was noted that the mitochondrial membrane potential
is affected only when cells were exposed to ≥ 200 μMo f
LA, while low LA concentrations (≥ 200 μM) were with-
out any affective. It was also observed that pre-treat-
ment with LA followed by supplementation with high
concentrations of LA induced significant increase in
fluorescence suggesting that mitochondrial membrane
loses its ability to function as an electron transporter
and aerobic respirator (Fig. 2) at the dose tested.
PUFAs enhance free radical generation [22] that may
be related to the loss of mitochondrial function.
Figure 6 Cell cytochrome C concentration. CK means case-control with medium. As the LA was dissolved in 0.1 N NaOH, NaOH group means
case-control with reagent. A, B, C, and D were four different treatments of the three cell lines. For HUVEC: A = 200 μM without LA pre-
treatment, B = 400 μM without LA pre-treatment, C = 200 μM with 100 μM LA pre-treatment, D = 400 μM with 100 μM LA pre-incubation. For
LOVO and RKO cells: A = 100 μM without LA pre-treatment, B = 300 μM without LA pre-treatment, C = 100 μM with 100 μM LA pre-
treatment, D = 300 μM with 100 μM LA pre-incubation. Each treatment was carried out in triplicate and repeated at least twice. *p < 0.05, and
**p < 0.01.
Figure 7 Cell caspase-9 activity. CK means case-control with medium. As LA was dissolved in 0.1 N NaOH, NaOH group means case-control
with reagent. A, B, C, and D were four different treatments of the three cell lines. For HUVEC: A = 200 μM without LA pre-treatment, B = 400
μM without LA pre-treatment, C = 200 μM with 100 μM LA pre-treatment, D = 400 μM with 100 μM LA pre-incubation, For LOVO and RKO
cells: A = 100 μM without LA pre-treatment, B = 300 μM without LA pre-treatment, C = 100 μM with 100 μM LA pre-treatment, D = 300 μM
with 100 μM LA pre-incubation. Each treatment was carried out in triplicate and repeated at least twice. *p < 0.05, and **p < 0.01.
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PUFAs could be correlated to an increase in generation
of free radicals [8]. We also noted that GLA induced
apoptosis of tumor cells by augmenting free radical gen-
eration only in the tumor cells but not normal cells
[23]. Based on the results of the present study and pre-
vious results [24], we suggest that free radical generation
is the main mediator of mitochondrial damage and
apoptosis of tumor cells. Despite similar treatment sche-
dules, the formation of ROS, lipid peroxides and the
degree of apoptosis were found to be dissimilar between
LOVO and RKO cells. It is noteworthy that the levels of
SOD were significantly elevated in RKO compared with
LOVO cells suggesting that oxidant stress is present to
a significant degree in the former but not the latter. The
increase in SOD levels in RKO could be secondary to
the accumulation of significant amounts of MDA in
these cells. The formation of ROS and lipid peroxides
were not significantly increased in HUVEC suggesting
that normal cells resist the formation of lipid peroxides
and generation of ROS and thus are able to with stand
oxidant stress induced by exposure to LA (Figs. 3, 4,
&5).
MDA formulation is mainly due to (a) non-enzymatic
free radical catalyzed lipid peroxidation and (b) AA
derived cyclooxygenase pathway that can be enhanced
by the addition of LA. Pre-treatment with LA (100 μM)
followed by supplementation of 100 and 300 μMo fL A
enhanced the formation of lipid peroxides (MDA forma-
t i o n )i nR K Oc e l l sc o m p a r e dw i t hH U V E Ca n dL O V O
cells suggesting that accumulation or formation of lipid
peroxides in cells may vary depending on the cell type.
These results imply that accumulation of lipid peroxides
may trigger apoptosis and generation of ROS and the
levels of SOD could be determined by the amount and
degree of lipid peroxides formed in the cells.
Mitochondrial dysfunction leads to apoptosis due to
the release of cytochrome C that, in turn, activates cas-
pase-9 and caspase-3. Oxidant stress can induce mito-
chondrial dysfunction, alter its membrane potential,
interrupt electron transport chain and induce apoptosis.
LA-treated tumor cells showed significantly enhanced
cytochrome C release, and activities of caspase-9 and
caspase-3 (Figs. 7 and 8). Enhanced activity of caspase-9
and cytochrome c release was observed in LA-pre-trea-
ted RKO tumor cells that support the proposal that
apoptosis in these cells are mediated by mitochondrial
pathway (Figure 9). These results suggest that accumula-
tion of LA in the tumor cells could facilitate apoptotic
process since LA-pre-treated tumor cells were found to
be much more vulnerable to apoptosis compared to
untreated tumor and normal cells.
Cell differentiation status could affect their sensitivity
to the cytotoxic actions of LA. This is supported by the
observation that the differentiated cell line RKO was
more sensitive to the cytotoxic action of LA in compari-
son to the undifferentiated cell line LOVO, especially
after pre-incubation with LA. These results imply that
LOVO cells may metabolize LA more efficiently and are
able to detoxify the toxic metabolites of LA in compari-
son to RKO cells. Hence, it will be interesting to study
the differential metabolic pathway of LA in RKO,
LOVO cells and HUVEC as related to its cytotoxic
action.
Figure 8 Cell caspase-3 activity. CK means case-control with medium. As LA was dissolved in 0.1 N NaOH, NaOH group means case-control
with reagent. A, B, C, and D were four different treatments of the three cell lines. For HUVEC: A = 200 μM without LA pre-treatment, B = 400
μM without LA pre-treatment, C = 200 μM with 100 μM LA pre-treatment, D = 400 μM with 100 μM LA pre-incubation, For LOVO and RKO
cells: A = 100 μM without LA pre-treatment, B = 300 μM without LA pre-treatment, C = 100 μM with 100 μM LA pre-treatment, D = 300 μM
with 100 μM LA pre-incubation. Each treatment was carried out in triplicate and repeated at least twice. *p < 0.05, and **p < 0.01.
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Page 9 of 11Although the results of the present study indicated that
colorectal cancer cell lines are more susceptible to the
cytotoxic effects of LA compared with human umbilical
endothelial cells, the inherent cell type differences may
also have influenced the differential respones observed
rather than tumor specific differences. Hence, more stu-
dies need to be performed to understand and elucidate the
molecular mechanism(s) of the cytotoxic action of LA.
In summary, it was observed that LA induces the forma-
tion of lipid peroxides that, in turn, could induce apoptosis
of tumor cells. The differential cytotoxicity observed in
two different colorectal cancer cell lines at different stages
of differentiation suggests that the handling of LA by these
cells is different and understanding its (LA) metabolism in
these cells may lead to the identification toxic metabolites
formed that drive its cytotoxic action.
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